![Transparency Market Researchが調査・発行した産業分析レポートです。世界のアルブミン市場2021年ｰ2031年：製品種類別（ヒト血清アルブミン、組換えアルブミン）、用途別、エンドユーザー別 / Albumin Market (Product Type: Human Serum Albumin and Recombinant Albumin; Application: Human Serum Albumin Application [Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, and In Vitro Fertilization] and Recombinant Albumin Applications [Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, and In Vitro Fertilization]; and End-user: Pharmaceutical & Biotechnology Companies, Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2204B016資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-47.gif) | • レポートコード：MRC2204B016 • 出版社/出版日：Transparency Market Research / 2022年4月20日 • レポート形態：英文、PDF、178ページ • 納品方法：Eメール • 産業分類：食品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料では、世界のアルブミン市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（ヒト血清アルブミン、組換えアルブミン）分析、用途別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめました。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のアルブミン市場規模：製品別（ヒト血清アルブミン、組換えアルブミン） ・世界のアルブミン市場規模：用途別 ・世界のアルブミン市場規模：エンドユーザー別 ・世界のアルブミン市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
TMR’s report on the global albumin market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global albumin market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global albumin market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global albumin market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global albumin market.
The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global albumin market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global albumin market.
The report delves into the competitive landscape of the global albumin market. Key players operating in the global albumin market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global albumin market that have been profiled in this report.
Key Questions Answered in Global Albumin Market Report
What is the scope of growth of product companies in the global albumin market?
What will be the Y-o-Y growth of the global albumin market between 2017 and 2031?
What is the influence of changing trends in technologies on the global albumin market?
Will Asia Pacific be the most profitable market for albumin providers?
Which factors are anticipated to hamper the growth of the global albumin market during the forecast period?
Which are the leading companies in the global albumin market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global albumin market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global albumin market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the albumin market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the albumin market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global albumin market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global albumin market more reliably and accurately.
Albumin Market – Segmentation
*** Product Type
Human Serum Albumin
Recombinant Albumin
*** Application
Human Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
Recombinant Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
*** End-user
Pharmaceutical & Biotechnology Companies
Research Institutes
Others
*** Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Albumin Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Albumin Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. Regulatory Scenario by Key Countries
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Albumin Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Human Serum Albumin
6.3.2. Recombinant Albumin
6.4. Market Attractiveness Analysis, by Product
7. Global Albumin Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Human Serum Albumin Applications
7.3.1.1. Drug Formulation
7.3.1.2. Drug Delivery
7.3.1.3. Vaccines
7.3.1.4. Medical Device Coating
7.3.1.5. Culture Media & Stabilizers
7.3.1.6. Diagnostics
7.3.1.7. In Vitro Fertilization
7.3.2. Recombinant Albumin Applications
7.3.2.1. Drug Formulation
7.3.2.2. Drug Delivery
7.3.2.3. Vaccines
7.3.2.4. Medical Device Coating
7.3.2.5. Culture Media & Stabilizers
7.3.2.6. Diagnostics
7.3.2.7. In Vitro Fertilization
8. Global Albumin Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Research Institutes
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Albumin Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Albumin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Human Serum Albumin
10.2.2. Recombinant Albumin
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Human Serum Albumin Applications
10.3.1.1. Drug Formulation
10.3.1.2. Drug Delivery
10.3.1.3. Vaccines
10.3.1.4. Medical Device Coating
10.3.1.5. Culture Media & Stabilizers
10.3.1.6. Diagnostics
10.3.1.7. In Vitro Fertilization
10.3.2. Recombinant Albumin Applications
10.3.2.1. Drug Formulation
10.3.2.2. Drug Delivery
10.3.2.3. Vaccines
10.3.2.4. Medical Device Coating
10.3.2.5. Culture Media & Stabilizers
10.3.2.6. Diagnostics
10.3.2.7. In Vitro Fertilization
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharmaceutical & Biotechnology Companies
10.4.2. Research Institutes
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Albumin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Human Serum Albumin
11.2.2. Recombinant Albumin
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Human Serum Albumin Applications
11.3.1.1. Drug Formulation
11.3.1.2. Drug Delivery
11.3.1.3. Vaccines
11.3.1.4. Medical Device Coating
11.3.1.5. Culture Media & Stabilizers
11.3.1.6. Diagnostics
11.3.1.7. In Vitro Fertilization
11.3.2. Recombinant Albumin Applications
11.3.2.1. Drug Formulation
11.3.2.2. Drug Delivery
11.3.2.3. Vaccines
11.3.2.4. Medical Device Coating
11.3.2.5. Culture Media & Stabilizers
11.3.2.6. Diagnostics
11.3.2.7. In Vitro Fertilization
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharmaceutical & Biotechnology Companies
11.4.2. Research Institutes
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Asia Pacific Albumin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Human Serum Albumin
12.2.2. Recombinant Albumin
12.3. Market Value Forecast by Application, 2017–2031
12.3.1. Human Serum Albumin Applications
12.3.1.1. Drug Formulation
12.3.1.2. Drug Delivery
12.3.1.3. Vaccines
12.3.1.4. Medical Device Coating
12.3.1.5. Culture Media & Stabilizers
12.3.1.6. Diagnostics
12.3.1.7. In Vitro Fertilization
12.3.2. Recombinant Albumin Applications
12.3.2.1. Drug Formulation
12.3.2.2. Drug Delivery
12.3.2.3. Vaccines
12.3.2.4. Medical Device Coating
12.3.2.5. Culture Media & Stabilizers
12.3.2.6. Diagnostics
12.3.2.7. In Vitro Fertilization
12.4. Market Value Forecast, by Product, 2017–2031
12.4.1. Pharmaceutical & Biotechnology Companies
12.4.2. Research Institutes
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. South Korea
12.5.4. India
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Albumin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Human Serum Albumin
13.2.2. Recombinant Albumin
13.3. Market Value Forecast by Application, 2017–2031
13.3.1. Human Serum Albumin Applications
13.3.1.1. Drug Formulation
13.3.1.2. Drug Delivery
13.3.1.3. Vaccines
13.3.1.4. Medical Device Coating
13.3.1.5. Culture Media & Stabilizers
13.3.1.6. Diagnostics
13.3.1.7. In Vitro Fertilization
13.3.2. Recombinant Albumin Applications
13.3.2.1. Drug Formulation
13.3.3. Drug Delivery
13.3.3.1. Vaccines
13.3.3.2. Medical Device Coating
13.3.3.3. Culture Media & Stabilizers
13.3.3.4. Diagnostics
13.3.3.5. In Vitro Fertilization
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharmaceutical & Biotechnology Companies
13.4.2. Research Institutes
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Albumin Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Human Serum Albumin
14.2.2. Recombinant Albumin
14.3. Market Value Forecast, by End-user, 2017–2031
14.3.1. Pharmaceutical & Biotechnology Companies
14.3.2. Research Institutes
14.3.3. Others
14.4. Market Value Forecast, by Country/Sub-region, 2017–2031
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East & Africa
14.5. Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By Application
14.5.3. By End-user
14.5.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Albumedix A/S
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Analysis
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Albumin Therapeutics, LLC
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Analysis
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Biotest AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Analysis
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. CSL Behring LLC
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Analysis
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Grifols International, S.A.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Analysis
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. HiMedia Laboratories Pvt. Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Analysis
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. InVitria
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Analysis
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Medxbio Pte Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Analysis
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Octapharma AG
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Analysis
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. RayBiotech, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Financial Analysis
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Seracare Life Sciences (LGC)
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Financial Analysis
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.11.5. SWOT Analysis
15.3.12. Sigma-Aldrich Co. (Merck KGaA)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Financial Analysis
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
15.3.13. Takeda Pharmaceutical Company Limited (Shire)
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Financial Analysis
15.3.13.3. Growth Strategies
15.3.13.4. SWOT Analysis
List of TablesTable 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031
Table 04: Global Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031
Table 05: Global Albumin Market Value (US$ Mn), Forecast, 2017–2031
Table 06: Global Albumin Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031
Table 11: North America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031
Table 12: North America Albumin Market Value (US$ Mn), Forecast, by End-user, 2017–2031
Table 13: Europe Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 14: Europe Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Europe Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031
Table 17: Europe Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031
Table 18: Europe Albumin Market Value (US$ Mn), Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 20: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 21: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 22: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031
Table 23: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031
Table 24: Asia Pacific Albumin Market Value (US$ Mn), Forecast, 2017–2031
Table 25: Latin America Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 26: Latin America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Latin America Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Latin America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031
Table 29: Latin America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031
Table 30: Latin America Albumin Market Value (US$ Mn), Forecast, 2017–2031
Table 31: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 32: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 33: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 34: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031
Table 35: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031
Table 36: Middle East & Africa Albumin Market Value (US$ Mn), Forecast, 2017–2031
List of Figures
Figure 01: Global Albumin market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Albumin market Value Share, by Product Type, 2020
Figure 03: Global Albumin market Value Share, by End-user, 2020
Figure 04: Global Albumin market Value Share, by Region, 2020
Figure 05: Global Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 06: Global Albumin Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 07: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin, 2017–2031
Figure 08: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin, 2017–2031
Figure 09: Global Albumin Market Value Share Analysis, by Application, 2020 and 2031
Figure 10: Global Albumin Market Attractiveness Analysis, by Application, 2021–2031
Figure 11: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin Applications, 2017–2031
Figure 12: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin Applications, 2017–2031
Figure 13: Global Albumin Market, by End-user, 2020 and 2031
Figure 14: Global Albumin Market, by End-user, 2021–2031
Figure 15: Global Albumin Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 16: Global Albumin Market (US$ Mn), by Research Institutes, 2017–2031
Figure 17: Global Albumin Market (US$ Mn), by Others, 2017–2031
Figure 18: Global Albumin Market Value Share Analysis, by Region, 2020 and 2031
Figure 19: Global Albumin Market Attractiveness Analysis, by Region, 2021–2031
Figure 20: North America Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 21: North America Albumin Market Value Share Analysis, by Country, 2020 and 2031
Figure 22: North America Albumin Market Attractiveness Analysis, by Country, 2021–2031
Figure 23: North America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 24: North America Albumin Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 25: North America Albumin Market Value Share Analysis, by Application, 2020 and 2031
Figure 26: North America Albumin Market Attractiveness Analysis, by Application, 2021–2031
Figure 27: North America Albumin Market, by End-user, 2020 and 2031
Figure 28: North America Albumin Market, by End-user, 2021–2031
Figure 29: Europe Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 30: Europe Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 31: Europe Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 32: Europe Albumin Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 33: Europe Albumin Market Value Share Analysis, by Application, 2020 and 2031
Figure 34: Europe Albumin Market Attractiveness Analysis, by Application, 2021–2031
Figure 35: Europe Albumin Market, by End-user, 2020 and 2031
Figure 36: Europe Albumin Market, by End-user, 2021–2031
Figure 37: Asia Pacific Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 38: Asia Pacific Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 39: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 40: Asia Pacific Albumin Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 41: Asia Pacific Albumin Market Value Share Analysis, by Application, 2020 and 2031
Figure 42: Asia Pacific Albumin Market Attractiveness Analysis, by Application, 2021–2031
Figure 43: Asia Pacific Albumin Market, by End-user, 2020 and 2031
Figure 44: Asia Pacific Albumin Market, by End-user, 2021–2031
Figure 45: Latin America Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 46: Latin America Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 47: Latin America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 48: Latin America Albumin Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 49: Latin America Albumin Market Value Share Analysis, by Application, 2020 and 2031
Figure 50: Latin America Albumin Market Attractiveness Analysis, by Application, 2021–2031
Figure 51: Latin America Albumin Market, by End-user, 2020 and 2031
Figure 52: Latin America Albumin Market, by End-user, 2021–2031
Figure 53: Middle East & Africa Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 54: Middle East & Africa Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 55: Middle East & Africa Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 56: Middle East & Africa Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 57: Middle East & Africa Albumin Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 58: Middle East & Africa Albumin Market Value Share Analysis, by Application, 2020 and 2031
Figure 59: Middle East & Africa Albumin Market Attractiveness Analysis, by Application, 2021–2031
Figure 60: Middle East & Africa Albumin Market, by End-user, 2020 and 2031
Figure 61: Middle East & Africa Albumin Market, by End-user, 2021–2031
Figure 62: Global Albumin Market Share, by Company, 2021